Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1

  1. Guo-Yun Chen
  2. Nicholas K Brown
  3. Wei Wu
  4. Zahra Khedri
  5. Hai Yu
  6. Xi Chen
  7. Diantha van de Vlekkert
  8. Alessandra D'Azzo
  9. Pan Zheng
  10. Yang Liu  Is a corresponding author
  1. Children's National Medical Center, United States
  2. Unversity of California, Davis, United States
  3. University of California, Davis, United States
  4. St Jude Children's Research Hospital, United States

Abstract

Both pathogen- and tissue damage-associated molecular patterns induce inflammation through toll-like receptors (TLRs), while sialic acid-binding immunoglobulin superfamily lectin receptors (Siglecs) provide negative regulation. Here we report extensive and direct interactions between these pattern recognition receptors. The promiscuous TLR binders were human SIGLEC-5/9 and mouse Siglec-3/E/F. Mouse Siglec-G did not show appreciable binding to any TLRs tested. Correspondingly, Siglece deletion enhanced dendritic cell responses to all microbial TLR ligands tested, while Siglecg deletion did not affect the responses to these ligands. TLR4 activation triggers Neu1 translocation to cell surface to disrupt TLR4:Siglec-E interaction. Conversely, sialidase inhibitor Neu5Gc2en prevented TLR4 ligand-induced disruption of TLR4:Siglec E/F interactions. Absence of Neu1 in hematopoietic cells or systematic treatment with sialidase inhibitor Neu5Gc2en protected mice against endotoxemia. Our data raised an intriguing possibility of a broad repression of TLR function by Siglecs and a sialidase-mediated de-repression that allows positive feedback of TLR activation during infection.

Article and author information

Author details

  1. Guo-Yun Chen

    Children's National Medical Center, Washington, DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Nicholas K Brown

    Children's National Medical Center, Washington, DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Wei Wu

    Children's National Medical Center, Washington, DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Zahra Khedri

    Unversity of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Hai Yu

    University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Xi Chen

    University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Diantha van de Vlekkert

    St Jude Children's Research Hospital, Memphis, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Alessandra D'Azzo

    St Jude Children's Research Hospital, Memphis, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Pan Zheng

    Children's National Medical Center, Washington, DC, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Yang Liu

    Children's National Medical Center, Washington, DC, United States
    For correspondence
    yaliu@cnmc.org
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Xuetao Cao, Zhejiang University School of Medicine, China

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (312-13-05) of the The Children's National Medical Center. Every effort was made to minimize suffering

Version history

  1. Received: July 17, 2014
  2. Accepted: August 28, 2014
  3. Accepted Manuscript published: September 3, 2014 (version 1)
  4. Version of Record published: September 19, 2014 (version 2)

Copyright

© 2014, Chen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,644
    views
  • 769
    downloads
  • 117
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Guo-Yun Chen
  2. Nicholas K Brown
  3. Wei Wu
  4. Zahra Khedri
  5. Hai Yu
  6. Xi Chen
  7. Diantha van de Vlekkert
  8. Alessandra D'Azzo
  9. Pan Zheng
  10. Yang Liu
(2014)
Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1
eLife 3:e04066.
https://doi.org/10.7554/eLife.04066

Share this article

https://doi.org/10.7554/eLife.04066

Further reading

    1. Immunology and Inflammation
    Xiuyuan Lu, Hiroki Hayashi ... Sho Yamasaki
    Research Article

    SARS-CoV-2 vaccines have been used worldwide to combat COVID-19 pandemic. To elucidate the factors that determine the longevity of spike (S)-specific antibodies, we traced the characteristics of S-specific T cell clonotypes together with their epitopes and anti-S antibody titers before and after BNT162b2 vaccination over time. T cell receptor (TCR) αβ sequences and mRNA expression of the S-responded T cells were investigated using single-cell TCR- and RNA-sequencing. Highly expanded 199 TCR clonotypes upon stimulation with S peptide pools were reconstituted into a reporter T cell line for the determination of epitopes and restricting HLAs. Among them, we could determine 78 S epitopes, most of which were conserved in variants of concern (VOCs). After the 2nd vaccination, T cell clonotypes highly responsive to recall S stimulation were polarized to follicular helper T (Tfh)-like cells in donors exhibiting sustained anti-S antibody titers (designated as ‘sustainers’), but not in ‘decliners’. Even before vaccination, S-reactive CD4+ T cell clonotypes did exist, most of which cross-reacted with environmental or symbiotic microbes. However, these clonotypes contracted after vaccination. Conversely, S-reactive clonotypes dominated after vaccination were undetectable in pre-vaccinated T cell pool, suggesting that highly responding S-reactive T cells were established by vaccination from rare clonotypes. These results suggest that de novo acquisition of memory Tfh-like cells upon vaccination may contribute to the longevity of anti-S antibody titers.

    1. Chromosomes and Gene Expression
    2. Immunology and Inflammation
    Rajan M Thomas, Matthew C Pahl ... Andrew D Wells
    Research Article

    Ikaros is a transcriptional factor required for conventional T cell development, differentiation, and anergy. While the related factors Helios and Eos have defined roles in regulatory T cells (Treg), a role for Ikaros has not been established. To determine the function of Ikaros in the Treg lineage, we generated mice with Treg-specific deletion of the Ikaros gene (Ikzf1). We find that Ikaros cooperates with Foxp3 to establish a major portion of the Treg epigenome and transcriptome. Ikaros-deficient Treg exhibit Th1-like gene expression with abnormal production of IL-2, IFNg, TNFa, and factors involved in Wnt and Notch signaling. While Ikzf1-Treg-cko mice do not develop spontaneous autoimmunity, Ikaros-deficient Treg are unable to control conventional T cell-mediated immune pathology in response to TCR and inflammatory stimuli in models of IBD and organ transplantation. These studies establish Ikaros as a core factor required in Treg for tolerance and the control of inflammatory immune responses.